Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Active not recruiting 6Completed 5Unknown 4Terminated 4Recruiting 4Withdrawn 2Not yet recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1Other 1Gastrointestinal 1

Conditions

Radiation Fibrosis Syndrome 1Pancreatic Neoplasms 1Lung Neoplasms 1Dyspnea 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Radiotherapy 91pembrolizumab 88Cyclophosphamide 84Gemcitabine 70Cisplatin 70Magnetic Resonance Spectroscopy 65Carboplatin 60Radiosurgery 55Paclitaxel 55Nivolumab 48Dexamethasone 45Bevacizumab 42Biopsy 41Fluorouracil 39durvalumab 37Surveys and Questionnaires 36Docetaxel 36fludarabine 35Doxorubicin 35Radiation 33Oxaliplatin 33Capecitabine 33Rituximab 32fludarabine phosphate 31Leucovorin 31Cytarabine 30Melphalan 29Etoposide 28Pemetrexed 27Irinotecan 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Withdrawn × OTHER × Losartan × Clear all
NCT05861336 2024-12-27

OVERPASS

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

Phase 2 Withdrawn
Gastrointestinal

Pancreatic Neoplasms

NCT00880386 2017-05-02

Losartan in Treating Pulmonary Fibrosis in Patients With Stage I, II, or III Non-Small Cell Lung Cancer

University of South Florida

Phase NA Withdrawn
OtherThoracic

Radiation Fibrosis Syndrome, Carcinoma, Non-Small-Cell Lung, Dyspnea, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡